Effect of Physical Training Combined Cardiac Resynchronization Therapy in Heart Failure Patients
1 other identifier
interventional
40
1 country
1
Brief Summary
The investigators hypothesis that exercise training would potentiate the effects of cardiac resynchronization therapy in heart failure patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Jan 2009
Longer than P75 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 27, 2013
CompletedFirst Posted
Study publicly available on registry
September 11, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedOctober 25, 2016
October 1, 2016
5.7 years
March 27, 2013
October 24, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sympathetic nerve activity
Sympathetic nerve activity will be assessed by microneurography
4 months
Secondary Outcomes (5)
Peak oxygen consumption
4 months
Quality of life
4 months
Blood inflammatory markers
4 months
skeletal muscle strength
4 months
Muscle Blood Flow
4 months
Study Arms (3)
Healthy People
NO INTERVENTIONControl group
Untrained CRT
EXPERIMENTALUntrained CRT patients
Exercise trained + CRT
EXPERIMENTALExercise-trained CRT patients
Interventions
Three 40-minute exercise sessions per week on a treadmill for four months
Eligibility Criteria
You may qualify if:
- QRS\> 150 ms or 120-150ms associated dyssynchrony
- The etiology can be idiopathic, ischemic, hypertensive and Chagas' disease
- Ejection fraction \<35%
You may not qualify if:
- Patients with pulmonary diseases, neurological diseases, renal, skeletal muscle diseases
- Patients with contraindications to implant a cardiac pacemaker
- Pregnancy
- New York Heart Association functional class IV
- Atrial fibrillation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Thais Simoes Nobre Pires Santos
São Paulo, São Paulo, 05403-000, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carlos E Negrao, Phd
InCor, HCFMUSP
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Phd student
Study Record Dates
First Submitted
March 27, 2013
First Posted
September 11, 2013
Study Start
January 1, 2009
Primary Completion
September 1, 2014
Study Completion
March 1, 2015
Last Updated
October 25, 2016
Record last verified: 2016-10